Celldex to Present at the Jefferies 2021 Virtual Healthcare Conference

Celldex Therapeutics (NASDAQ:CLDX) announced participation in the Jefferies 2021 Virtual Healthcare Conference on June 2, 2021, at 1:30 p.m. ET.

Rhea-AI Summary

Celldex Therapeutics (NASDAQ:CLDX) announced participation in the Jefferies 2021 Virtual Healthcare Conference on June 2, 2021, at 1:30 p.m. ET. Senior management will engage in a fireside chat during the event. Interested parties can access the webcast through the Events & Presentations page on their website. A replay of the chat will be available for 30 days post-event.

Argus Session date unavailable

+2.58% session move Open Argus

Details

News Market Reaction – CLDX

The recorded move for CLDX in the trading session of this news was +2.58%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

HAMPTON, N.J., May 26, 2021 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that senior management will participate in a fireside chat at the Jefferies 2021 Virtual Healthcare Conference on Wednesday, June 2, 2021 at 1:30 p.m. ET.

A webcast of the presentation will be available on the "Events & Presentations" page of the "Investors & Media" section of the Celldex website. A replay will be available for 30 days following the event.

About Celldex Therapeutics, Inc.
Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer. Visit www.celldex.com.

Company Contact
Sarah Cavanaugh
Senior Vice President, Corporate Affairs & Administration
(508) 864-8337
scavanaugh@celldex.com

Patrick Till
Senior Director, Investor Relations & Corporate Communications
(484) 788-8560
ptill@celldex.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is the Jefferies 2021 Virtual Healthcare Conference for Celldex Therapeutics?

The Jefferies 2021 Virtual Healthcare Conference for Celldex Therapeutics is scheduled for June 2, 2021, at 1:30 p.m. ET.

How can I access the webcast for Celldex Therapeutics' presentation?

The webcast for Celldex Therapeutics' presentation can be accessed on the Events & Presentations page of their website.

Will there be a replay available for Celldex's presentation at the conference?

Yes, a replay of Celldex Therapeutics' presentation will be available for 30 days following the event.

What is the main focus of Celldex Therapeutics?

Celldex Therapeutics focuses on developing monoclonal and bispecific antibodies for treating diseases with inadequate available treatments.

What stock symbol does Celldex Therapeutics trade under?

Celldex Therapeutics trades under the stock symbol CLDX.